Talkspace, Inc. (TALK) fair value analysis
Nasdaq · Updated 2026-09-07
Talkspace, Inc. is a digital mental health platform that provides therapy and psychiatric services through licensed therapists and psychiatrists via online video, phone, and messaging. The company operates throughout the United States and serves patients seeking mental health treatment remotely.
Valuation status
Awaiting full valuationTALK does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under our standards — we require at least six validated trailing price-to-earnings windows before publishing one. TickrTrends re-evaluates every covered stock weekly; a verdict publishes automatically once enough validated history accumulates.
- Last price
- $5.21
- Sector
- Healthcare
- 12-month range
- $2.70–$5.23
Derived indicators
Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.
- Quality grade
- D
- Leverage
- Low
- 50/200-day trend
- Mixed
- 52-week position
- The top quarter of its range
What our data shows for TALK
- Our model validated 4 trailing price-to-earnings windows for TALK, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $2.70–$5.23.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for TALK
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.
Recent TALK news
TickrTrends' derived news-sentiment signal for TALK is currently mixed, computed from recent coverage.
- Even Therapists Have Become a Data Mine (armstrongeconomics.com, 2026-05-27)
TickrTrends take: The article explores how therapist data and patient information are increasingly monetized, which presents both revenue opportunities and regulatory risks for healthcare companies like TALK operating in this space. For valuation purposes, investors should monitor how TALK manages the tension between data commercialization potential and compliance costs, as healthcare data handling directly impacts profit margins and legal exposure. With TickrTrends currently awaiting full valuation on TALK, clarification on the company's data governance practices and their financial implications will be important inputs for establishing a complete valuation framework. - Why Billionaire George Soros Is Betting Big on Talkspace Stock (finance.yahoo.com, 2026-05-24)
TickrTrends take: Billionaire investor George Soros's significant stake in Talkspace represents a notable endorsement from a prominent financial figure, though TickrTrends currently awaits sufficient data to establish a full valuation assessment for the Healthcare sector company. Valuation-focused readers should monitor how this high-profile backing influences analyst coverage, earnings revisions, and investor demand, as these factors could provide additional data points needed to complete a comprehensive valuation picture. The trajectory of TALK's financial metrics and market reception following major investor involvement typically shapes the foundation for valuation frameworks in the telehealth space. - Talkspace (TALK) Delivered an Immediate Return. Here’s How (finance.yahoo.com, 2026-05-05)
TickrTrends take: Talkspace operates in the Healthcare sector where valuation metrics are particularly important for assessing whether recent returns represent sustainable business performance or temporary market movements. With TickrTrends currently awaiting full valuation analysis on TALK, investors focused on fundamental value should monitor whether any near-term gains are accompanied by improvements in the underlying financial metrics that typically drive healthcare company valuations. The distinction between immediate price returns and durable business value creation will be critical for understanding TALK's position once a complete valuation picture emerges.
What people are saying
Follow the TALK conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is TALK stock undervalued?
TALK does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under TickrTrends' standards; it is re-evaluated every week.
What is TALK's TickrTrends verdict?
TALK is currently marked 'Awaiting full valuation' - a verdict publishes automatically once at least six validated trailing P/E windows accumulate.
Is TALK overbought or oversold?
TickrTrends does not currently publish an RSI signal for TALK.